Latest Breaking News On - Brixton biosciences secures - Page 1 : comparemela.com

Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by.

United statesSameer sabirBrixton biosciencesMichael fishmanSv health investorsCatalyst health venturesSparta groupCentric pain solutionsBrixton biosciences securesAdvance novel pain therapiesChief executive officerShould knowSchooner capitalExcelestar venturesCatalyst healthChief medical